Autologous neural stem cells
/ Future Pak
- LARVOL DELTA
Home
Next
Prev
1 to 2
Of
2
Go to page
1
April 12, 2022
Transplantation of Neural Stem Cell-Derived Neurons for Parkinson's Disease
(clinicaltrials.gov)
- P1/2 | N=0 | Withdrawn | Sponsor: NeuroGeneration | N=12 ➔ 0 | Trial completion date: Jun 2023 ➔ Jun 2024 | Not yet recruiting ➔ Withdrawn | Trial primary completion date: Dec 2022 ➔ Dec 2023
Enrollment change • Trial completion date • Trial primary completion date • Trial withdrawal • CNS Disorders • Movement Disorders • Parkinson's Disease • Solid Tumor • Transplantation
July 23, 2020
Molecular Analysis of Human Neural Stem Cells
(clinicaltrials.gov)
- P=N/A; N=20; Enrolling by invitation; Sponsor: NeuroGeneration; Trial completion date: Dec 2021 ➔ Dec 2023; Trial primary completion date: Dec 2020 ➔ Dec 2022
Biomarker • Clinical • Trial completion date • Trial primary completion date • CNS Disorders • Gene Therapies • Movement Disorders • Parkinson's Disease
1 to 2
Of
2
Go to page
1